6533b85dfe1ef96bd12be80e
RESEARCH PRODUCT
Utility of the PHQ-9 to identify major depressive disorder in adult patients in Spanish primary care centres.
Leonardo Adrián MedranoRoger Muñoz-navarroAna María Hermosilla-pasamarFlorian SchmitzMaria Antonia Font-payerasAntonio Cano-vindelCarmen Abellán-maesoPaloma Ruiz-rodríguezsubject
AdultMalemedicine.medical_specialtyPsychometricsPsychometricslcsh:RC435-571Primary careMajor depressive disorderPatient Health Questionnairebehavioral disciplines and activitiesSensitivity and Specificity03 medical and health sciences0302 clinical medicinePredictive Value of Testslcsh:Psychiatrymental disordersMedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive Disorder MajorPrimary Health Carebusiness.industryPatient health questionnaire-9medicine.diseasePrimary carePatient Health QuestionnaireDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPsychometric propertiesMoodPsychologieSpainPredictive value of testsMajor depressive disorderAnxietyFemalemedicine.symptombusiness030217 neurology & neurosurgeryClinical psychologyResearch Articledescription
Abstract Background The prevalence of major depressive disorder (MDD) in Spanish primary care (PC) centres is high. However, MDD is frequently underdiagnosed and consequently only some patients receive the appropriate treatment. The present study aims to determine the utility of the Patient Health Questionnaire-9 (PHQ-9) to identify MDD in a subset of PC patients participating in the large PsicAP study. Methods A total of 178 patients completed the full PHQ test, including the depression module (PHQ-9). Also, a Spanish version of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) was implemented by clinical psychologists that were blinded to the PHQ-9 results. We evaluated the psychometric properties of the PHQ-9 as a screening tool as compared to the SCID-I as a reference standard. Results The psychometric properties of the PHQ-9 for a cut-off value of 10 points were as follows: sensitivity, 0.95; specificity, 0.67. Using a cut-off of 12 points, the values were: sensitivity, 0.84; specificity, 0.78. Finally, using the diagnostic algorithm for depression (DSM-IV criteria), the sensitivity was 0.88 and the specificity 0.80. Conclusions As a screening instrument, the PHQ-9 performed better with a cut-off value of 12 versus the standard cut-off of 10. However, the best psychometric properties were obtained with the DSM-IV diagnostic algorithm for depression. These findings indicate that the PHQ-9 is a highly satisfactory tool that can be used for screening MDD in the PC setting. Trial registration Current Controlled Trials ISRCTN58437086 . Registered 20 May 2013.
year | journal | country | edition | language |
---|---|---|---|---|
2017-03-24 | BMC psychiatry |